- Home
- PBYI vs BEEP Comparison
PBYI vs BEEP Comparison
Compare PBYI & BEEP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PBYI
- BEEP
- Stock Information
- Founded
- PBYI 2010
- BEEP 2015
- Country
- PBYI United States
- BEEP United States
- Employees
- PBYI N/A
- BEEP N/A
- Industry
- PBYI Biotechnology: Pharmaceutical Preparations
- BEEP Blank Checks
- Sector
- PBYI Health Care
- BEEP Finance
- Exchange
- PBYI Nasdaq
- BEEP Nasdaq
- Market Cap
- PBYI 171.7M
- BEEP 150.7M
- IPO Year
- PBYI N/A
- BEEP N/A
- Fundamental
- Price
- PBYI $4.64
- BEEP $3.29
- Analyst Decision
- PBYI Strong Buy
- BEEP Strong Buy
- Analyst Count
- PBYI 1
- BEEP 2
- Target Price
- PBYI $7.00
- BEEP $6.75
- AVG Volume (30 Days)
- PBYI 648.1K
- BEEP 29.3K
- Earning Date
- PBYI 11-06-2025
- BEEP 11-11-2025
- Dividend Yield
- PBYI N/A
- BEEP N/A
- EPS Growth
- PBYI 434.29
- BEEP N/A
- EPS
- PBYI 0.97
- BEEP N/A
- Revenue
- PBYI $238,062,000.00
- BEEP $36,142,000.00
- Revenue This Year
- PBYI N/A
- BEEP $1.29
- Revenue Next Year
- PBYI N/A
- BEEP $5.56
- P/E Ratio
- PBYI $4.76
- BEEP N/A
- Revenue Growth
- PBYI 8.63
- BEEP 6.15
- 52 Week Low
- PBYI $2.32
- BEEP $2.65
- 52 Week High
- PBYI $6.07
- BEEP $4.86
- Technical
- Relative Strength Index (RSI)
- PBYI 49.99
- BEEP 35.79
- Support Level
- PBYI $4.49
- BEEP $3.51
- Resistance Level
- PBYI $5.22
- BEEP $3.78
- Average True Range (ATR)
- PBYI 0.26
- BEEP 0.22
- MACD
- PBYI -0.12
- BEEP -0.06
- Stochastic Oscillator
- PBYI 22.33
- BEEP 4.91
About PBYI Puma Biotechnology Inc
Puma Biotechnology Inc is a biopharmaceutical company that develops and commercializes inventive products to enhance cancer care and improve treatment outcomes for patients. It is currently commercializing NERLYNX, an oral version of neratinib, for the treatment of HER2-positive breast cancer. Also it develops alisertib. Alisertib is a selective, small-molecule inhibitor of aurora kinase A that is designed to disrupt mitosis resulting into apoptosis of rapidly proliferating tumor cells that are dependent on aurora kinase A.
About BEEP Mobile Infrastructure Corporation
Mobile Infrastructure Corp focuses on acquiring, owning, and leasing parking facilities and related infrastructure, including parking lots, parking garages and other parking structures throughout the United States. The company owns forty three parking facilities in twenty one separate markets throughout the United States, with a total of approximately fifteen thousand seven hundred parking spaces. It operates in a single reportable segment: parking. The company derives majority of revenue from Percentage rental income.